https://doctransparency.com/doctor/tx/houston/david-brown-1548368509
Medicare Enrolled

Dr. David Brown, M.D.

Ophthalmology · Houston, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
6560 FANNIN ST, Houston, TX 77030
7135243434
In practice since 2006 (19 years)
NPI: 1548368509 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Brown from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Brown? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Brown

Dr. David Brown is an ophthalmology in Houston, TX, with 19 years in practice. Based on federal Medicare data, Dr. Brown performed 17,331 Medicare services across 3,477 unique beneficiaries.

Between the years covered by Open Payments, Dr. Brown received a total of $407,457 from 44 pharmaceutical and/or device companies across 430 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Brown is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 6% volume in TX$ $407,457 industry payments

Medicare Practice Summary

Medicare Utilization ↗
17,331
Medicare services
Top 6% in TX for ophthalmology
3,477
Unique beneficiaries
$326
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~912 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Injection, pegcetacoplan, intravitreal, 1 mg4,080$120$451
Aflibercept eye injection (Eylea)3,466$694$2,709
Retinal imaging (OCT scan)2,970$30$127
Eye injection for retinal disease2,158$107$520
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg1,611$218$839
Comprehensive eye exam, established patient1,300$91$396
Unclassified drugs465$2,009$7,843
Unclassified biologics454$2,032$7,687
Injection, ranibizumab, 0.1 mg391$170$775
New patient office visit (45-59 min)97$124$521
Retinal photography (fundus photo)90$29$116
Eye exam, established patient, focused70$69$280
Exam of retinal blood vessels and blood vessels between the white part of eye and retina using a special camera after injection of a dye59$205$788
Comprehensive eye exam, new patient52$101$469
Exam of retinal blood vessels using a special camera after injection of a dye44$112$394
Office visit, established patient (30-39 min)24$94$400
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$407,457
Total received (2018-2024)
Avg $58,208/year across 7 years
Top 1% in TX for ophthalmology
44
Companies
430
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$392,358 (96.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,099 (3.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,000 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$52,326
2023
$82,706
2022
$47,932
2021
$40,535
2020
$100,629
2019
$29,796
2018
$53,533

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Regeneron Pharmaceuticals, Inc.
$100,833
Novartis Pharma AG
$58,502
Novartis Pharmaceuticals Corporation
$50,296
Optos plc
$44,327
Celltrion, Inc.
$31,320
Apellis Pharmaceuticals, Inc.
$22,151
Janssen Research & Development, LLC
$11,672
Regeneron Healthcare Solutions, Inc.
$10,287
Boehringer Ingelheim International GmbH
$8,910
Alexion Pharmaceuticals, Inc.
$7,475
Ocular Therapeutix, Inc.
$6,355
Merck Sharp & Dohme Corporation
$6,150
Boehringer Ingelheim Pharmaceuticals, Inc.
$5,811
Carl Zeiss Meditec, Inc.
$5,687
Kowa Research Institute, Inc.
$4,800
Biogen, Inc.
$4,282
Samsung Bioepis Co., Ltd.
$3,900
Genentech USA, Inc.
$3,492
OPTOS PLC
$3,375
Genentech, Inc.
$3,333
Allergan Inc.
$2,783
EyePoint Pharmaceuticals US, Inc.
$2,321
Allergan, Inc.
$2,031
Optos Plc
$1,500
OPTOS, INC.
$1,000
ABBVIE INC.
$989
Horizon Therapeutics plc
$850
Astellas Pharma US Inc
$485
Heidelberg Engineering, Inc.
$465
Carl Zeiss Meditec USA, Inc.
$314
Alcon Vision LLC
$251
Coherus Biosciences Inc.
$201
Janssen Pharmaceuticals, Inc
$184
McKesson Specialty Care Distribution, LLC
$182
AbbVie Inc.
$147
Harrow Eye, LLC
$139
CARDINAL HEALTH 108 LLC
$136
US Oncology Corporate, Inc.
$135
ASD Specialty Healthcare, LLC
$134
Amgen Inc.
$96
Hoffmann-La Roche Limited
$70
Optos, Inc.
$42
Medinc of Texas
$29
DePuy Synthes Sales Inc.
$16
Top 3 companies account for 51.4% of total payments
Associated products mentioned in payments ›
BEOVU · BLZ_BEOVU_OPHTHALMOLOGY · BROLUCIZUMAB · BUPARLISIB · BYOOVIZ · CIRRUS HD-OCT · CLARUS · Cimerli · Constellation · DEXTENZA · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · EYP-1901 · Humphrey HFA · IHEEZO · Izervay · Lucentis · MONOVISC · NFC-700 · NGENUITY · Non-Covered Product · OZURDEX · P200DTx · P200TxE · PANORAMIC OPHTHALMOSCOPE · PLEX Elite 9000 · RTH258A_BEOVU_OPHTHALMOLOGY · ReSure Sealant · SIMBRINZA · SUSVIMO · Spectralis · Syfovre · Vabysmo · XARELTO · YUTIQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (96%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 1% for ophthalmology in TX.

Equivalent to $2,351 per 100 Medicare services performed
Looking for a ophthalmology in Houston?
Compare ophthalmologys in the Houston area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologys nearby

Geographic Context

Ophthalmologys within 10 mi
298
Per 100K population
6.3
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Brown is a mixed practice specialist, with above-average Medicare volume (top 6% in TX), and high industry engagement (consulting-driven, top 1%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Brown experienced with injection, pegcetacoplan, intravitreal, 1 mg?
Based on Medicare claims data, Dr. Brown performed 4,080 injection, pegcetacoplan, intravitreal, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Brown receive payments from pharmaceutical companies?
Yes. Dr. Brown received a total of $407,457 from 44 companies across 430 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Brown's costs compare to other ophthalmologys in Houston?
Dr. Brown's average Medicare payment per service is $326. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Brown) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →